​
Login / Signup
Ying Chen
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 3
Top Topics
Patient Reported
Cell Proliferation
Long Noncoding Rna
Advanced Non Small Cell Lung Cancer
Top Venues
Evidence-based complementary and alternative medicine : eCAM
BioMed research international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xiaojing Qian
,
Shan Lin
,
Ji Li
,
Chenglin Jia
,
Yun Luo
,
Rui Fan
,
Cheng Hu
,
Ying Chen
Fisetin Ameliorates Diabetic Nephropathy-Induced Podocyte Injury by Modulating Nrf2/HO-1/GPX4 Signaling Pathway.
Evidence-based complementary and alternative medicine : eCAM
2023 (2023)
Wenmin Dong
,
Huiqian Zhang
,
YanCheng Dai
,
Yi Zhou
,
Yun Luo
,
Cheng Zhao
,
Yiyuan Cao
,
Yuping Du
,
Ying Chen
circRNA circFAT1(e2) Elevates the Development of Non-Small-Cell Lung Cancer by Regulating miR-30e-5p and USP22.
BioMed research international
2021 (2021)
Zehua Zhou
,
Ying Chen
,
Wenmin Dong
,
Rui An
,
Kun Liang
,
Xinhong Wang
Da Cheng Qi Decoction Alleviates Cerulein-Stimulated AR42J Pancreatic Acinar Cell Injury via the JAK2/STAT3 Signaling Pathway.
Evidence-based complementary and alternative medicine : eCAM
2021 (2021)